Search
Search
Invitrogen
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
图: 1 / 1
Please note: We are reviewing Western blot images included in the antibody testing data in our catalog, including those provided by third parties. Unless expressly labeled or annotated as “raw-unedited”, Western blot images included in the antibody testing data in our catalog may have been edited, optimized or otherwise adjusted for presentation.
4-Furazolidone metabolite, specifically 3-(4-cyano-2-oxobutylideneamino)-2-oxazolidone, is a known degradation product of furazolidone in mammals, fish, and Escherichia coli. This metabolite does not exhibit detectable antibacterial activity, indicating its limited functional role post-metabolism. Furazolidone itself is a nitrofuran derivative with antiprotozoal and antibacterial properties, primarily used to treat infectious diarrhea by binding bacterial DNA and inhibiting monoamine oxidase. The metabolism of furazolidone involves complex enzymatic processes, and understanding these metabolites is crucial for assessing drug efficacy and potential toxicity.
仅用于科研。不用于诊断过程。未经明确授权不得转售。